Botanix Pharmaceuticals Ltd
Times are shown in GMT+11, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.Botanix Pharmaceuticals Ltd is a clinical stage medical dermatology company. It is engaged in developing medical dermatology products for treating skin diseases including acne, psoriasis and atopic dermatitis.
Latest BOT News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News